The largest database of trusted experimental protocols

5 protocols using ab20921

1

Flow Cytometric Analysis of IAV NP

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used for flow cytometric staining: anti-IAV NP (Abcam, ab20921), Mouse IgG1 isotype control (Abcam, ab91356). Intracellular staining was performed using the BD Cytofix/Cytoperm kit (Becton Dickinson, 554714), according to the manufacturers instructions. All samples were run on a Guava easyCyte HT cytometer (Millipore) and analyzed using Flowjo (version 10.4.2, TreeStar)
+ Open protocol
+ Expand
2

Antibody-Dependent Cell-Mediated Phagocytosis of Influenza Virus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolation of human neutrophils from peripheral blood was carried out by using Ficoll-Paque PLUS density gradient (GE Healthcare) according to the procedures described previously [51 (link)]. ADCP by THP1 cells (from ATCC) and neutrophils was performed essentially as a previous report [52 (link)]. Control IgG was purchased from GeneTex (GTX16193). Briefly, Cal/09 virus was incubated with indicated antibodies at 37°C for 1 h and added to the sialidase (0.5 unit/mL, Sigma) pre-treated THP-1 cells or neutrophils. After 1 h incubation, THP-1 cells or neutrophils were washed three times with RPMI and incubated at 37°C. After 6 h incubation, THP-1 cells or neutrophils were fixed in 4% paraformaldehyde, permeabilized and stained with anti-influenza NP antibody (Abcam, Ab20921, 1:100 dilution). The levels of phagocytosis were monitored by flow cytometry.
+ Open protocol
+ Expand
3

Influenza Virus Nucleoprotein Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Infected cells were detected by flow cytometry using an anti-influenza A virus nucleoprotein 1 (FITC) antibody [431] (Abcam, Cambridge, UK: ab20921), as previously described (16) .
+ Open protocol
+ Expand
4

Dual Detection of Influenza A and Streptococcus pneumoniae

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single or mixed infected cells were washed with PBS, fixed with 4% paraformaldehyde for 20 minutes at room temperature, permeabilized in PBS-0.1% Triton X-100, and incubated with PBS containing 1% BSA and 3% human serum to block non-specific binding. Mouse monoclonal anti-Influenza A Virus Nucleoprotein (#ab20921; Abcam, Cambridge, United Kingdom) and goat anti-mouse IgG H&L (AF-488, #A11029; Life Technologies) were used to detect IAV. Rabbit polyclonal anti-Streptococcus pneumoniae antibody (#ab20429; Abcam) and goat anti-rabbit IgG H&L (AF-647, #ab150083; Abcam) were used to detect SP. Cells were imaged using a Leica DMI 3000B microscope equipped for fluorescence imaging.
+ Open protocol
+ Expand
5

Quantifying Influenza A Virus Lung Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The degree of IAV infection was determined by measuring the relative proportion of lung cells expressing influenza nuclear protein (NP) in lung homogenate from infected and control mice. Briefly the lungs from infected mice (or naïve controls) were homogenized to single cell suspension by pressing them through a 100m nylon mesh strainer and incubated with red blood cell lysis buffer (Roche #11814389001) for 5 minutes at 4C. Cell viability was assessed using Live/Dead stain (Thermofisher L23102), with monoclonal mouse antiinfluenza A virus nucleoprotein antibody conjugated to FITC (Abcam #ab20921) to determine infection. The percentage of live lung cells infected with IAV was determined by using flow cytometry (BC Epics XL-MCL flow cytometer) by gating on live cells expressing nucleoprotein on the FL1 FITC channel. We determined the percentage of lung cells expressing influenza NP; and therefore infected with influenza A virus.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!